Description of the medicine: Grippferon (Grippferonum)
A mixture of recombinant human α 2 -interferon with polyvinylpyrrolidone, polyethylene oxide and trilon B.
It is proposed as an antiviral drug for the treatment of influenza and other acute respiratory viral diseases.
Assign intranasally to adults in 3 drops (3000 IU) every 3-4 hours; children from 1 year to 3 years and 3-14 years - 2 drops (2000 IU), respectively, 3 and 4 times a day.
Contraindications: severe forms of allergic diseases, pregnancy.
Release form: solution (nasal drops) in 10 ml dropper bottles (10,000 IU / ml).